Spearhead Capital Advisors, LLC Exact Sciences Corp Transaction History

Spearhead Capital Advisors, LLC

  • $92.3 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 28, 2021
SELL
$116.57 - $155.01 $319,518 - $424,882
-2,741 Closed
0 $0
Q4 2020

Feb 02, 2021
SELL
$99.61 - $142.12 $8,168 - $11,653
-82 Reduced 2.9%
2,741 $363,000
Q3 2020

Oct 16, 2020
BUY
$72.92 - $102.01 $14,292 - $19,993
196 Added 7.46%
2,823 $288,000
Q2 2020

Jul 16, 2020
BUY
$55.75 - $92.75 $146,455 - $243,654
2,627 New
2,627 $228,000

Others Institutions Holding EXAS

# of Institutions
676
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Spearhead Capital Advisors, LLC Portfolio

Follow Spearhead Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email